QDIS Blog

A blog about chemistry, drug development, science, and technology

February 26, 2007

FDA Approves Eli Lilly’s Cymbalta for Generalized Anxiety Disorder

by Ed Vawter @ 2:33 pm.  Filed under FDA, Pharma News

LIlly received additional approvals for Cymbalta for treatment of generalized anxiety disorder.

Press Release: FDA Approves Eli Lilly and Company Cymbalta - FierceBiotech:

This brings to three the number of indications for this drug. The others include depression and diabetic neuropathy.

Technorati Tags: , ,

Email Ed Vawter



Related Posts:
  • FDA approves Shire’s ADHD drug Vyvanse
  • Merck Gets Approval for Emend for Post-operative Vomiting and Nausea
  • Gilead in Trouble over HIV Drug Marketing
  • FDA Warns of Dangers of Internet Drugs
  • FDA’s Approves pharmaceutical formulation intermediate (PFI)

    • Bookmark it with: | del.icio.us del.icio.us | Digg It Digg it | Furl Furl | Simpy Simpy | Spurl Spurl | My! Yahoo My Yahoo! |

    Leave a Reply

    [powered by WordPress.]

    QDIS: blogging about chemistry, drug development, science and technology.

    Internal Links

    Categories

    Search This Blog

    Archives

    February 2007
    S M T W T F S
    « Jan   Mar »
     123
    45678910
    11121314151617
    18192021222324
    25262728  

    Search Entire Site

    Subscribe (It's Free!)

    Performancing

    Chemistry, science, and technology for the future.

    logo2

    General Links

    Blog Links

    Chemistry Journal Feeds

    Chemistry Feeds

    35 queries. 0.892 seconds